Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China

被引：0
|
作者：
Huang, Kun [1 ]
Liu, Guoqing [1 ]
Wu, Runhui [1 ]
Chen, Zhenping [1 ]
Zhen, Yingzi [1 ]
Wu, Xinyi [1 ]
机构：
[1] Beijing Childrens Hosp, Beijing, Peoples R China
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
emicizumab; FVIII inhibitor; haemophilia A;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FP-09.02 (
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Breaking barriers in haemophilia A care: One-year real-world experience with emicizumab prophylaxis at Civil Service Hospital, Kathmandu, Nepal
    Poudyal, Bishesh Sharma
    Bajracharya, Nikesh
    Paudel, Bishal
    Karki, Bikram
    Acharya, Devendra
    Shrestha, Nripesh Man
    Gelal, Sanjay
    Shrestha, Anima
    Rizal, Laxmi
    Rajbahak, Jagat Lal
    Joshi, Utsav
    Kouides, Peter
    HAEMOPHILIA, 2024,
  • [32] Experience of prophylaxis with Emicizumab in Ivoirian boys with severe haemophilia A: Preliminary data
    Lambert, Catherine
    Meite, N'Dogomo
    Sanogo, Ibrahima
    Hermans, Cedric
    HAEMOPHILIA, 2022, 28 : 17 - 17
  • [33] Real-world cost estimates of initiating emicizumab in US patients with haemophilia A
    Samelson-Jones, Benjamin J.
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Raffini, Leslie
    HAEMOPHILIA, 2021, 27 (04) : 591 - 598
  • [34] Haemophilia in a real-world setting: the value of clinical experience in data collection
    Dolan, Gerry
    Iorio, Alfonso
    Jokela, Vuokko
    Juusola, Kristian
    Lassila, Riitta
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 : 3 - 9
  • [35] REAL-WORLD EXPERIENCE OF PATIENTS WITH HAEMOPHILIA A SWITCHING TO RVIII-SINGLECHAIN PROPHYLAXIS IN SPAIN
    Jimenez-Barcenas, R.
    Nunez-Vazquez, R. J.
    Pedrote-Amador, B.
    Rodriguez-Martorell, F. J.
    Perez-Simon, J. A.
    HAEMOPHILIA, 2021, 27 : 117 - 117
  • [36] Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A
    Dunn, A. L.
    Ahuja, S. P.
    Mullins, E. S.
    HAEMOPHILIA, 2018, 24 (03) : E84 - E92
  • [37] REAL-WORLD EXPERIENCE WITH EMICIZUMAB IN AN ITALIAN PAEDIATRIC COHORT: FOCUS ON PUPS AND TOLERIZED CHILDREN
    Pollio, B.
    Ricca, I
    Linari, C.
    Martinoli, C.
    Albiani, R.
    HAEMATOLOGICA, 2021, 106 (09) : 15 - 15
  • [38] Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie
    HAEMOPHILIA, 2020, 26 (04) : 631 - 636
  • [39] Real experience of prophylaxis with emicizumab in patients with congenital haemophilia A with and without FVIII inhibitors in the HCUVA
    Heredia Cano, Angela
    Garcia Candel, Faustino
    Sanchez Villalobos, Maria
    Poveda Garcia, Andrea
    Torchia Esteban, Marcos
    Ruiz Ruiz, Estela
    Sanchez Salas, Jose Antonio
    Navarro Almenzar, Begona
    Caracena Lopez, Sara
    Perez Laencina, Marta
    Blazquez Soto, Juan Antonio
    HAEMOPHILIA, 2024, 30 : 31 - 32
  • [40] Real world experience with Emicizumab in severe haemophilia A (HA) in Senegal, West Africa
    Diop, Saliou
    Seck, Moussa
    Mbomboa, Safiya
    Martin, Jayson
    Toure, Sokhna Aissatou
    Senghor, Alioune Badara
    Bousso, Elimane Seydi
    Keita, Mohamed
    Diallo, Alioune Badara
    Faye, Blaise Felix
    Sy, Diariatou
    Haffar, Assad
    HAEMOPHILIA, 2022, 28 : 69 - 70
12345